<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV</h1>
    <p class="timestamp">Published: 2023-10-31 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>On August 4, 2023, the United States Food and Drug Administration approved a new drug application for ZURZUVAE (zuranolone) capsules for the treatment of post-partum depression. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place zuranolone and its salts in schedule IV of the Controlled Substances Act (CSA). In accordance with the CSA, as amended by the Improving Regulatory Transparency for New Medical Therapies...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Justice Department, Drug Enforcement Administration</p>
    <p><strong>Document Number:</strong> 2023-23982</p>
    <p><strong>Publication Date:</strong> 2023-10-31</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/10/31/2023-23982/schedules-of-controlled-substances-placement-of-zuranolone-in-schedule-iv">https://www.federalregister.gov/documents/2023/10/31/2023-23982/schedules-of-controlled-substances-placement-of-zuranolone-in-schedule-iv</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-23982</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
